Methotrexate by injection, rather than by pill, getting more attention as treatment option

Methotrexate, the decades-old psoriasis treatment still commonly prescribed for psoriasis and psoriatic arthritis, is getting more attention recently as evidence seems to be building that injecting methotrexate under the skin…

Psoriasis & Psoriatic Arthritis Treatment Options

Methotrexate can cause fetal death, so never use methotrexate if pregnant, or if pregnancy is a possibility. Methotrexate can harm the liver, particularly if mixed with alcohol (or in a…

Alternative & Complementary Strategies for Psoriasis

There are several important complementary and natural measures – backed by significant scientific evidence – that can assist psoriasis treatment. A few of them are: Folic acid supplements during methotrexate

Treatments for Inverse, Guttate, Pustular, & Erythrodermic Psoriasis

…Drug Administration (FDA) approved for a different use. Many off-label uses are universally accepted – for example, methotrexate being used for psoriatic arthritis. But off-label use also adds more art…

“Fail first” insurance mandates not just a problem for U.S. psoriasis patients

…biologics are only covered by the Newfoundland and Labrador government with special authorization, after patients exhaust a gauntlet of other treatments. Patients must have tried Methotrexate, a chemotherapy agent and…

Psoriatic Arthritis

…In fact, both diseases respond to many of the same medications, especially methotrexate and the biologic therapies that target the immune system. Two or three percent of patients with RA…

Do I need to worry about links between psoriasis and Alzheimer’s disease?

…were acitretin (used commonly as a treatment in South Korea), methotrexate, cyclosporine, and biologic agents (like Enbrel, Humira, etc.). Here are the key findings: As compared to people without psoriasis,…

Cosentyx goes head to head against Humira in psoriatic arthritis…it’s mostly a draw

…treatments; while in actual practice, methotrexate is commonly used with biologics for psoriatic arthritis. In addition, the study did not look at “inhibition of radiographic progression,” which measures how much…

The Latest Psoriasis News

Company behind Humira and Skyrizi asks regulators to green-light Rinvoq for psoriatic arthritis

AbbVie, the North Chicago company behind the longtime blockbuster biologic Humira (adalimumab) and the new biologic Skyrizi (risankizumab-rzaa), has asked the U.S. Food and Drug Administration (FDA) and its European counterpart to approve its rheumatoid arthritis (RA) drug Rinvoq (upadacitinib) for psoriatic arthritis. Rinvoq is a JAK inhibitor administered as Continue Reading…

Our new “Psoriasis Journey” campaign is rolling out

Our new Psoriasis Journey campaign is rolling out now to prep for for an official June 8, 2020 launch. On that date, our volunteer patient with severe psoriasis is going to begin one of the cutting-edge psoriasis treatments we’ve been hearing so much about. You can follow along with his Continue Reading…

Want to try an experimental psoriasis treatment for your skin or scalp?

Before a doctor can prescribe a treatment, it goes through years of research and testing, including multiple rounds of clinical trials, using volunteer patients to test a potential treatment’s safety and effectiveness. The clinical trials are developed in consultation with government regulators (here, the US Food and Drug Administration, or Continue Reading…